Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-04 | Dr. Kunkel received her B.A. in Biology from the University of California San Diego and an M.D. from the University of Southern California. She completed her internal medicine internship and residency at Baylor College of Medicine, Affiliated Hospitals. In addition she completed her hematology fellowship at University of Southern California and her medical oncology fellowship at University of California Los Angeles. |
| 2018-04-03 | Dr. Kunkel received her B.A. in Biology from the University of California San Diego and an M.D. from the University of Southern California. We believe that Dr. Kunkel’s qualifications to serve on our board include her expertise in hematology and oncology as well as her extensive and valuable industry experience in pharmaceutical and biotechnology companies in developing and commercializing oncologic/immunologic therapies. |
| 2019-04-11 | Dr. Kunkel received her B.A. in Biology from the University of California San Diego and an M.D. from the University of Southern California. She completed her internal medicine internship and residency at Baylor College of Medicine, Affiliated Hospitals. In addition she completed her hematology fellowship at University of Southern California and her medical oncology fellowship at University of California Los Angeles. We believe that Dr. Kunkel’s qualifications to serve on our board include her expertise in hematology and oncology as well as her extensive and valuable industry experience in pharmaceutical and biotechnology companies in developing and commercializing oncologic/immunologic therapies. |
| 2020-04-22 | Dr. Kunkel received her B.A. in Biology from the University of California San Diego and an M.D. from the University of Southern California. We believe that Dr. Kunkel’s qualifications to serve on our board include her expertise in hematology and oncology as well as her extensive and valuable industry experience in pharmaceutical and biotechnology companies in developing and commercializing oncologic/immunologic therapies. |
| 2021-04-14 | Dr. Kunkel received her B.A. in Biology from the University of California San Diego and an M.D. from the University of Southern California. She has extensive and valuable industry experience with pharmaceutical and biotechnology companies developing and commercializing oncologic/immunologic therapies. |
| 2022-04-13 | Dr. Kunkel received her B.A. in Biology from the University of California San Diego and an M.D. from the University of Southern California. We believe that Dr. Kunkel’s qualifications to serve on our board include her expertise in hematology and oncology as well as her extensive and valuable industry experience with pharmaceutical and biotechnology companies. |
Data sourced from SEC filings. Last updated: 2026-02-03